EADV 2026: Placebo Response in Hidradenitis Suppurativa Trials
Placebo responses can complicate the interpretation of clinical trials investigating immunomodulatory treatments for hidradenitis suppurativa (HS). In this MEDtalk, Nina Qiu, Medical Student, Bispebjerg Hospital, Copenhagen, Denmark, presents a systematic review and meta-analysis of 39 randomized controlled trials, exploring the magnitude of placebo responses, factors associated with them, and their implications for future trial design.






